|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/095 | (2019.01) |
| A61P 1/16 | (2018.01) | ||
| A61K 38/08 | (2019.01) | ||
| A61P 1/00 | (2018.01) | ||
| C07K 7/16 | (2006.01) | ||
| A61K 38/095 | (2019.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 1/00 | (2006.01) |
| (11) | Number of the document | 3347032 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16818751.6 |
| Date of filing the European patent application | 2016-06-30 | |
| (97) | Date of publication of the European application | 2018-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/040284 |
| Date | 2016-06-30 |
| (87) | Number | WO 2017/004317 |
| Date | 2017-01-05 |
| (30) | Number | Date | Country code |
| 201562186638 P | 2015-06-30 | US | |
| 201562267510 P | 2015-12-15 | US | |
| 201662321558 P | 2016-04-12 | US |
| (72) |
ANGELI, Paolo , IT
MARKHAM, Penelope , US
ADAMS, Jonathan , US
|
| (73) |
BioVie Inc. ,
680 W. Nye Lane
Suite 204, Carson City, NV 89703,
US
|
| (54) | TERLIPRESSIN FOR THE TREATMENT OF ASCITES DUE TO LIVER CIRRHOSIS ADMINISTERED AS A CONTINUOUS INFUSION |
| TERLIPRESSIN FOR THE TREATMENT OF ASCITES DUE TO LIVER CIRRHOSIS ADMINISTERED AS A CONTINUOUS INFUSION |